Efficacy of Front-Line Ibrutinib and Rituximab Combination and the Impact of Treatment Discontinuati...
Efficacy of Front-Line Ibrutinib and Rituximab Combination and the Impact of Treatment Discontinuation in Unfit Patients with Chronic Lymphocytic Leukemia: Results of the Gimema LLC1114 Study
About this item
Full title
Author / Creator
Mauro, Francesca Romana , Paoloni, Francesca , Molica, Stefano , Reda, Gianluigi , Trentin, Livio , Sportoletti, Paolo , Marchetti, Monia , Pietrasanta, Daniela , Marasca, Roberto , Gaidano, Gianluca , Coscia, Marta , Stelitano, Caterina , Mannina, Donato , Di Renzo, Nicola , Ilariucci, Fiorella , Liberati, Anna Marina , Orsucci, Lorella , Re, Francesca , Tani, Monica , Musuraca, Gerardo , Gottardi, Daniela , Zinzani, Pier Luigi , Gozzetti, Alessandro , Molinari, Annalia , Gentile, Massimo , Chiarenza, Annalisa , Laurenti, Luca , Varettoni, Marzia , Ibatici, Adalberto , Murru, Roberta , Ruocco, Valeria , Del Giudice, Ilaria , De Propris, Maria Stefania , Della Starza, Irene , Raponi, Sara , Nanni, Mauro , Fazi, Paola , Neri, Antonino , Guarini, Anna , Rigolin, Gian Matteo , Piciocchi, Alfonso , Cuneo, Antonio and Foà, Robin
Publisher
Switzerland: MDPI AG
Journal title
Language
English
Formats
Publication information
Publisher
Switzerland: MDPI AG
Subjects
More information
Scope and Contents
Contents
The GIMEMA group investigated the efficacy, safety, and rates of discontinuations of the ibrutinib and rituximab regimen in previously untreated and unfit patients with chronic lymphocytic leukemia (CLL). Treatment consisted of ibrutinib, 420 mg daily, and until disease progression, and rituximab (375 mg/sqm, given weekly on week 1–4 of month 1 and...
Alternative Titles
Full title
Efficacy of Front-Line Ibrutinib and Rituximab Combination and the Impact of Treatment Discontinuation in Unfit Patients with Chronic Lymphocytic Leukemia: Results of the Gimema LLC1114 Study
Authors, Artists and Contributors
Author / Creator
Paoloni, Francesca
Molica, Stefano
Reda, Gianluigi
Trentin, Livio
Sportoletti, Paolo
Marchetti, Monia
Pietrasanta, Daniela
Marasca, Roberto
Gaidano, Gianluca
Coscia, Marta
Stelitano, Caterina
Mannina, Donato
Di Renzo, Nicola
Ilariucci, Fiorella
Liberati, Anna Marina
Orsucci, Lorella
Re, Francesca
Tani, Monica
Musuraca, Gerardo
Gottardi, Daniela
Zinzani, Pier Luigi
Gozzetti, Alessandro
Molinari, Annalia
Gentile, Massimo
Chiarenza, Annalisa
Laurenti, Luca
Varettoni, Marzia
Ibatici, Adalberto
Murru, Roberta
Ruocco, Valeria
Del Giudice, Ilaria
De Propris, Maria Stefania
Della Starza, Irene
Raponi, Sara
Nanni, Mauro
Fazi, Paola
Neri, Antonino
Guarini, Anna
Rigolin, Gian Matteo
Piciocchi, Alfonso
Cuneo, Antonio
Foà, Robin
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8750939
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8750939
Other Identifiers
ISSN
2072-6694
E-ISSN
2072-6694
DOI
10.3390/cancers14010207
